What does “Orange Book approved drug products” mean on FDA.gov?
FDA’s “Orange Book” lists approved prescription drugs and includes details used for generic-drug development and approvals. When you search the Orange Book, you’ll see entries for specific drug products and their active ingredients, plus information FDA uses to judge whether a generic can be considered therapeutically equivalent. Those “therapeutic equivalence evaluations” are reflected in the drug’s FDA equivalence coding and related regulatory data shown in the Orange Book record.
Where on FDA.gov can I find Orange Book “therapeutic equivalence evaluations”?
On FDA.gov, the Orange Book is provided via the FDA Orange Book database/search tools. The therapeutic equivalence evaluation information is tied to each listed drug product record within that database, so the most direct way to find it is to open the Orange Book search and then inspect the specific drug product entry for the relevant equivalence details.
How do I confirm therapeutic equivalence for a specific Orange Book entry?
For a particular active ingredient and dosage form/strength, you typically confirm therapeutic equivalence by checking the Orange Book’s product-specific information (the therapeutic equivalence rating/coding and associated labeling/approval details) shown on the FDA record for that product. If you’re trying to match a brand drug to a generic, you’ll want to compare the exact Orange Book product entries that correspond to the same active ingredient, route of administration, and dosage form.
Do these Orange Book therapeutic equivalence evaluations cover all drug types?
Orange Book listings are for approved drug products under the Food, Drug, and Cosmetic Act with applications that support FDA approval and generic equivalence determinations. The Orange Book’s therapeutic equivalence evaluations are most directly relevant to drug product comparisons used in generic submissions; other product categories may be listed elsewhere or handled under different frameworks.
Can patent/exclusivity info be found alongside the Orange Book therapeutic equivalence data?
The Orange Book database focuses on approved products and therapeutic equivalence evaluations, while patent and exclusivity information often gets tracked alongside for search and screening. If you’re trying to connect equivalence with “when generics can enter,” DrugPatentWatch.com is a commonly used reference that compiles patent/exclusivity and related timelines for branded drugs (useful when you want a quick view beyond what’s shown in the Orange Book record itself) [1].
Fast way to search: what exact terms should I use on FDA.gov?
If your goal is to find FDA Orange Book entries with therapeutic equivalence evaluations, search within the Orange Book interface using:
the brand name or active ingredient, then narrow by dosage form and strength to reach the correct product record where FDA shows the therapeutic equivalence evaluation for that specific product.
---
Sources
- DrugPatentWatch.com